IFNA1 and dermatomyositis: Some researchers in this area believe that measuring type-I IFN-inducible transcripts is a more sensitive and better tool to gauge diseases activity than to measuring serum free IFN-α levels [10, 16–18] as Type I IFN inducible transcripts in the blood of dermatomyositis patients have thus far correlated better with disease activity [19–22].